Q. 2-deoxy-D-glucose (2-DG), which was recently approved by the DCGI, has been developed by which institution?
Answer:
DRDO
Notes: The Drugs Controller General of India (DCGI) has approved the emergency use of drug 2-deoxy-D-glucose (2-DG), in moderate to severe Covid-19 patients.
The drug was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories, Hyderabad.